iMedicor Unveils Solution for the Secure Transfer of Disparate Electronic Medical Records

NANUET, N.Y.--(BUSINESS WIRE)--iMedicor, a Vemics Company (OTCBB: VMCI), today announced the unveiling of its proprietary technology solution that addresses the long-standing and widespread inability of disparate Electronic Health Records (EHR) systems to communicate, collaborate and exchange medical records in a HIPAA compliant environment.

“Vemics iMedicor portal delivers on the Obama Administration’s call for a secure, interoperable health information infrastructure that will enable healthcare providers to become interconnected,” said Vemics chief executive officer Fred Zolla. “iMedicor’s technology facilitates the transfer of medical records and images between disparate Electronic Health Record (EHR) systems in real time, and provides the critical first step in allowing the healthcare community to communicate electronically through secure messaging specifically designed to compliment clinical workflow.”

iMedicor’s technology provides physicians, healthcare providers and patients with the capability of transporting medical records in a manner that eliminates the risk of them being intercepted or altered. The portal, which also provides physicians with a social and professional referral network and access to continuing medical education programs, is available to health care organizations, professionals and patients free of charge at www.imedicor.com.

After registering with iMedicor, healthcare professionals and patients are prompted to fill out a profile. Each U.S. Physician has a pre-populated Curriculae Vitae (CV) by tapping one of the most extensive databases of physician information available. Each CV contains as many as 193 data points on each physician.

This profile information enhances the community component of iMedicor as all users can be located through the iMedicor internal search engine as a comprehensive registry. Users may also remain anonymous if they choose. Most importantly, physicians have the ability to look up other physicians for referral purposes, and patients can locate physicians for treatment and e-consults. Once a patient/physician relationship is confirmed within iMedicor, a secure sub-network is created for safe, private information exchange.

In addition, iMedicor employs a proprietary driver that allows for the exportation of documents and images from any EHR system. iMedicor also facilitates the exchange of Continuity of Care Record (CCR) files between users.

“We look forward to working with Dr. David Blumenthal, the U.S. Department of Health and Human Services’ National Coordinator for Health Information Technology, to adopt the solution called for in The American Recovery and Reinvestment Act of 2009 (ARRA) that was signed into law by President Obama on February 17th, 2009," said Tom Dorsett, President of iMedicor.

iMedicor was launched in limited Beta format in October 2007 to test and refine the system and ensure that it would provide the connectivity needed by the healthcare community. In 2009, Version 2.0 of the iMedicor platform was released - the first free, comprehensive solution for community-based, secure messaging for every physician, healthcare professional, and patient in the United States.

Vemics’ iMedicor portal can also deliver the highest quality CME (Continuing Medical Education) programs sponsored by medical societies, pharmaceutical companies, medical device companies and the U.S. Military.

iMedicor is based in Austin, Texas. Vemics’ corporate offices are located in Nanuet, New York. www.vemics.com, www.imedicor.com.

The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of Vemics' products and services; the nonexclusive and terminable-at-will nature of certain of the company's partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission.